| Literature DB >> 19114019 |
Rüdiger Smektala1, Heinz G Endres, Burkhard Dasch, Christoph Maier, Hans J Trampisch, Felix Bonnaire, Ludger Pientka.
Abstract
BACKGROUND: Whether reducing time-to-surgery for elderly patients suffering from hip fracture results in better outcomes remains subject to controversial debates.Entities:
Mesh:
Year: 2008 PMID: 19114019 PMCID: PMC2627842 DOI: 10.1186/1471-2474-9-171
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Patient characteristics, stratified by time-to-surgery
| Group | I | II | III | p-value |
| Time from fracture to surgery | ≤ 12 h | > 12 h to ≤ 36 h | > 36 h | |
| Cases (total = 2916) | n = 802 | n = 1191 | n = 923 | |
| Female (2324; 79.7%) n (%) | 654 (81.6) | 953 (80.0) | 717 (77.7) | 0.13 |
| Age in years (mean, std) interquartile range | 82.4 (7.5) | 82.4 (7.5) | 81.5 (7.2) | 0.009 (I/II: n.s.; I/III: 0.04; II/III: 0.01) |
| 77.2–88.8 | 77.3–88.5 | 76.8–87.2 | ||
| Patients ≥ 85 years n (%) | 308 (38.4) | 455 (38.2) | 289 (31.3) | 0.001 |
| ASA classificationA | ||||
| ASA I/II n (%) | 324 (40.4) | 454 (38.3) | 298 (32.3) | |
| ASA III n (%) | 447 (55.7) | 685 (57.7) | 554 (60.1) | |
| ASA IV/V n (%) | 31 (3.9) | 48 (4.0) | 70 (7.6) | < 0.001 |
| Body mass index (kg/m2) | ||||
| < 25 | 462 (60.7) | 669 (60.5) | 544 (62.6) | |
| 25–29.9 | 235 (30.9) | 340 (30.8) | 251 (28.9) | |
| ≥ 30 | 64 (8.4) | 96 (8.7) | 74 (8.5) | 0.88 |
| Smoking status | ||||
| Non-smoker | 676 (90.6) | 981 (89.2) | 759 (88.1) | |
| Smoker | 70 (9.4) | 119 (10.8) | 103 (11.9) | 0.25 |
| Arterial hypertension | ||||
| No | 256 (32.6) | 363 (30.9) | 288 (31.5) | |
| Yes | 530 (67.4) | 812 (69.1) | 625 (68.5) | 0.74 |
| Diabetes mellitus | ||||
| No | 594 (75.7) | 918 (78.4) | 674 (74.6) | |
| Yes | 191 (24.3) | 253 (21.6) | 230 (25.4) | 0.10 |
| Myocardial infarction | ||||
| No | 701 (93.0) | 1016 (91.4) | 788 (91.7) | |
| Yes | 53 (7.0) | 96 (8.6) | 71 (8.3) | 0.44 |
| PAOD B | ||||
| No | 595 (80.7) | 872 (78.4) | 673 (77.4) | |
| Yes | 142 (19.3) | 240 (21.6) | 196 (22.6) | 0.26 |
| Stroke | ||||
| No | 640 (86.5) | 949 (85.8) | 716 (82.9) | |
| Yes | 100 (13.5) | 157 (14.2) | 148 (17.1) | 0.08 |
| COPD C | ||||
| No | 658 (87.0) | 976 (86.5) | 780 (88.3) | |
| Yes | 98 (13.0) | 153 (13.5) | 103 (11.7) | 0.45 |
| Malignancy | ||||
| No | 641 (88.4) | 975 (90.8) | 764 (89.2) | |
| Yes | 84 (11.6) | 99 (9.2) | 93 (10.8) | 0.24 |
| Creatinine > 2 mg/dl | ||||
| No | 706 (91.9) | 1027 (90.5) | 799 (90.0) | |
| Yes | 62 (8.1) | 108 (9.5) | 89 (10.0) | 0.37 |
| Type of admission | ||||
| from own home | 612 (77.0) | 927 (78.0) | 677 (73.6) | |
| from nursing institution | 152 (19.1) | 223 (18.8) | 177 (19.2) | |
| from clinic/hospital | 31 (3.9) | 38 (3.2) | 66 (7.2) | < 0.001 |
n.s. = not significant
A American Society of Anesthesiologists ratings; B peripheral arterial occlusive disease; C Chronic obstructive pulmonary disease
Fracture type and operative procedure, stratified by time-to-surgery
| Group | I | II | III | p-value |
| Time from fracture to surgery | ≤ 12 h | > 12 h to ≤ 36 h | > 36 h | |
| Cases (total = 2916) | n = 802 | n = 1191 | n = 923 | |
| Femoral neck fracture | 277 (34.5) | 584 (49.0) | 605 (65.6) | |
| Pertrochanteric femoral fracture | 525 (65.5) | 607 (51.0) | 318 (34.4) | < 0.001 |
| TEP A | ||||
| No | 738 (92.0) | 1039 (87.2) | 789 (85.5) | < 0.001 |
| Yes | 64 (8.0) | 152 (12.8) | 134 (14.5) | |
| HEP B | ||||
| No | 630 (78.6) | 830 (69.7) | 516 (55.9) | < 0.001 |
| Yes | 172 (21.4) | 361 (30.3) | 407 (44.1) | |
| Osteosynthesis | ||||
| No | 246 (30.7) | 538 (45.2) | 546 (59.2) | < 0.001 |
| Yes | 556 (69.3) | 653 (54.8) | 377 (40.8) | |
| Length of operation | ||||
| < 60 min | 324 (41.4) | 466 (40.0) | 356 (39.6) | |
| ≥ 60 to < 120 min | 398 (50.9) | 624 (53.6) | 480 (53.5) | |
| ≥ 120 min | 60 (7.7) | 74 (6.4) | 62 (6.9) | 0.68 |
| Anesthesia procedure | ||||
| General anesthetic | 597 (74.9) | 840 (71.8) | 672 (74.1) | |
| Regional anesthetic | 200 (25.1) | 330 (28.2) | 235 (25.9) | 0.26 |
| Intra- and post-op. blood products | ||||
| none | 377 (48.4) | 532 (46.1) | 444 (50.0) | |
| 1–2 units | 300 (38.5) | 441 (38.2) | 312 (35.1) | |
| 3–4 units | 79 (10.1) | 142 (12.3) | 99 (11.2) | |
| > 4 units | 23 (3.0) | 40 (3.4) | 33 (3.7) | 0.42 |
A Total endoprostheses; B Hemi endoprostheses
Rate of postoperative complications, requiring treatment, stratified by time-to-surgery
| Group | I | II | III | p-value |
| Time from fracture to surgery | ≤ 12 h | > 12 h – ≤ 36 h | > 36 h | |
| Cases (total = 2916) | n = 802 | n = 1191 | n = 923 | |
| Cardiovascular complications | ||||
| No | 778 (97.0) | 1149 (96.5) | 885 (95.9) | |
| Yes | 24 (3.0) | 42 (3.5) | 38 (4.1) | 0.45 |
| Pneumonia | ||||
| No | 787 (98.1) | 1156 (97.1) | 895 (97.0) | |
| Yes | 15 (1.9) | 35 (2.9) | 28 (3.0) | 0.25 |
| Pulmonary embolism/thrombosis | ||||
| No | 799 (99.6) | 1185 (99.5) | 914 (99.0) | |
| Yes | 3 (0.4) | 6 (0.5) | 9 (1.0) | 0.23 |
| Urinary tract infection | ||||
| No | 745 (92.9) | 1103 (92.6) | 836 (90.6) | |
| Yes | 57 (7.1) | 88 (7.4) | 87 (9.4) | 0.13 |
| Bed sores | ||||
| No | 797 (99.4) | 1171 (98.3) | 908 (98.4) | |
| Yes | 5 (0.6) | 20 (1.7) | 15 (1.6) | 0.10 |
| Post-op. bleeding/Hematoma | ||||
| No | 760 (94.8) | 1140 (95.7) | 894 (96.9) | |
| Yes | 42 (5.2) | 51 (4.3) | 29 (3.1) | 0.09 |
| Abcess (epi-/subfascial) | ||||
| No | 783 (97.6) | 1166 (97.9) | 903 (97.8) | |
| Yes | 19 (2.4) | 25 (2.1) | 20 (2.2) | 0.92 |
| Implant complications | ||||
| No | 777 (96.9) | 1170 (98.2) | 900 (97.5) | |
| Yes | 25 (3.1) | 21 (1.8) | 23 (2.5) | 0.14 |
Implant complications = misalignment, dislocation, breakage of implant, endoprothestic luxation
Mortality rates, stratified by time-to-surgery
| Group | I | II | III | p-value |
| Time from fracture to surgery | ≤ 12 h | > 12 h – ≤ 36 h | > 36 h | |
| Cases (total = 2916) | n = 802 | n = 1191 | n = 923 | |
| One-year mortality | ||||
| No | 657 (81.9) | 947 (79.5) | 739 (80.1) | |
| Yes | 145 (18.1) | 244 (20.5) | 184 (19.9) | 0.40 |
Hazard ratios (multivariable-adjusted) for death of any causes within one year after discharge
| HR (95% CI); p-value | |
| Time from fracture to surgeryA | 1.04 (0.93 to 1.16); p = 0.55 |
| AgeB | 1.05 (1.04 to 1.06); p < 0.001 |
| SexC | 0.72 (0.58 to 0.88); p = 0.002 |
| ASAD | 1.60 (1.37 to 1.88); p < 0.001 |
| BMIE | 1.38 (1.16 to 1.65); p < 0.001 |
| MalignancyF | 1.84 (1.46 to 2.32); p < 0.001 |
| Kidney dysfunctionG | 1.34 (1.05 to 1.71); p = 0.02 |
| COPD | 1.39 (1.11 to 1.75); p = 0.004 |
| Post-op complication – cardiovascular | 1.87 (1.33 to 2.63); p < 0.001 |
| Post-op complication – decubitus ulcers | 2.08 (1.20 to 3.58); p = 0.009 |
| Post-op complication – stroke | 2.37 (1.05 to 5.32); p = 0.037 |
| Post-op complication – implant | 0.97 (0.54 to 1.75); p = 0.92 |
A 0 ≤ 12 h, 12 h < 1 ≤ 36 h, 2 > 36 h; B age in years; C 1 = men 2 = women; D three ASA groups (American Society of Anesthesiologists ratings): 1 = ASA1 or ASA2, 2 = ASA3, 3 = ASA4 or ASA5; E Body mass index according to ESPEN limits for age 65+ (0: 22.0 to < 30.0; 1: < 22.0 or ≥ 30.0); F malignancy in patient history; G kidney impairment in patient history;
Risk of post-operative complications (multivariable-adjusted) as a function of time-to-surgery
| Pulmonary embolism/thrombosis | 1.72 (0.85–3.50); p = 0.133 |
| Cardiovascular | 1.13 (0.87–1.48); p = 0.369 |
| Pneumonia | 1.16 (0.85–1.58); p = 0.365 |
| Implant | 0.91 (0.66–1.26); p = 0.562 |
| Vascular injury | 0.24 (0.03–1.80); p = 0.165 |
| Bleeding | 0.75 (0.59–0.97); p = 0.026 |
| Bed sores | 1.33 (0.86–2.05); p = 0.201 |
A Time-to-surgery interval I (≤ 12 h) vs. II (> 12 h–≤ 36 h) vs. III (> 36 h); OR = odds ratio; CI = confidence interval, multivariable-adjusted for age, sex, ASA categories, BMI ESPEN, diabetes, and hypertension